The Livingston Group for Titan Pharmaceuticals
Pharmaceutical, makes and markets Probuphine, an implant to treat opioid addiction.
Based in CA
AI Overview
With $20K in lobbying spend across 3 quarterly filings, The Livingston Group for Titan Pharmaceuticals is an active lobbying client. Their lobbying covers 6 issue areas. Active from 2018 to 2019.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $10K |
| 2019 | $10K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that The Livingston Group for Titan Pharmaceuticals disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Defense, Veterans, Pharmacy, Law Enforcement, Alcohol & Drug Abuse and 1 more
FDA labeling change for Probuphine
Encourage federal agencies to utilize Medication Assisted Treatment (MAT) for the treatment of opioid addiction. Work for a FDA label change for probuphine.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.